NeuBase Therapeutics, Inc. Payments for Restructuring
NeuBase Therapeutics, Inc. reported Payments for Restructuring of $503.15 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-11-09
- NeuBase Therapeutics, Inc. payments for restructuring for the quarter ending 2023-09-30 was $180.39K.
- NeuBase Therapeutics, Inc. payments for restructuring for the quarter ending 2023-06-30 was $0.00.
- NeuBase Therapeutics, Inc. payments for restructuring for the quarter ending 2023-03-31 was $322.76K.
- NeuBase Therapeutics, Inc. payments for restructuring for the quarter ending 2022-12-31 was $336.42K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2023-09-30 | $180.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $180.39K derived: sum of 2 quarters · filed 2023-11-09 | $503.15K 10-Q · filed 2023-11-09 | $839.57K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $322.76K 10-Q · filed 2023-08-14 | $659.18K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2023-03-31 | $322.76K 10-Q · filed 2023-05-11 | $659.18K derived: sum of 2 quarters · filed 2023-06-05 | ||
| 2022-12-31 | $336.42K 10-QT · filed 2023-06-05 |